Theron Odlaug

Theron E. Odlaug, PhD, is an accomplished professional with extensive experience in the healthcare sector, currently serving as Operating Partner at Signet Healthcare Partners since January 2017. Odlaug holds advisory and leadership roles in various organizations, including Chair of the Board of Directors at Pharma Nobis, LLC, and Member of the Board of Advisors at Regis Technologies. Odlaug is also a Member of the Board of Directors for both Ascendia and the Dravet Syndrome Foundation, contributing to advancements in research and treatment for rare medical conditions. As Managing Partner at EIR Healthcare Consultants LLC since April 2006 and a former Co-President at TLGY Acquisition Corporation, Odlaug has demonstrated a strong focus on healthcare consulting and investment. Educational credentials include a PhD in Public Health, Sterilization Technology from the University of Minnesota, complemented by advanced degrees in Biology from the University of Missouri-Kansas City.